<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1419905" created="21/02/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>1419905</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Activation of <term id="T1" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> by <term id="T2" lex="interleukin_2" sem="Protein_molecule">interleukin 2</term> in <term id="T3" lex="human_blood_monocyte" sem="Cell_natural"><term id="T4" lex="human" sem="Multicellular_organism_natural">human</term> blood <term id="T5" lex="monocyte" sem="Cell_natural">monocytes</term></term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="T1"/>
<cause idref="T2"/>
<clue><clueType>Activation</clueType> <linkTheme>of</linkTheme> NF-kappa B <linkCause>by</linkCause> interleukin 2 <clueLoc>in human blood monocytes</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">We report here that <term id="T6" lex="interleukin_2" sem="Protein_molecule">interleukin 2</term> (<term id="T7" lex="IL-2" sem="Protein_molecule">IL-2</term>) acts on <term id="T8" lex="human_blood_monocyte" sem="Cell_natural"><term id="T9" lex="human" sem="Multicellular_organism_natural">human</term> blood <term id="T10" lex="monocyte" sem="Cell_natural">monocytes</term></term> by enhancing binding activity of the <term id="T11" lex="transcription_factor_NF-kappa_B" sem="Protein_molecule">transcription factor <term id="T12" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term></term> to its consensus sequence in the <term id="T13" lex="5&apos;_regulatory_enhancer_region" sem="DNA_substructure">5&apos; regulatory enhancer region</term> of the <term id="T14" lex="IL-2_receptor_alpha_chain" sem="DNA_domain_or_region"><term id="T15" lex="IL-2" sem="Protein_molecule">IL-2</term> receptor alpha chain</term> (<term id="T16" lex="p55" sem="Protein_molecule">p55</term>).</sentence>
<event id="E2">
<type class="Binding"/>
<theme idref="T12"/>
<theme idref="T14"/>
<clue>We report here that interleukin 2 (IL-2) acts on human blood monocytes by enhancing <clueType>binding activity</clueType> <linkTheme>of</linkTheme> the transcription factor NF-kappa B <linkTheme>to</linkTheme> its consensus sequence in the 5&apos; regulatory enhancer region of the IL-2 receptor alpha chain (p55).</clue>
</event>
<event id="E3">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="T7"/>
<clue>We <clueKT>report</clueKT> here that interleukin 2 (IL-2) acts on human blood monocytes by <clueType>enhancing</clueType> binding activity of the transcription factor NF-kappa B to its consensus sequence in the 5&apos; regulatory enhancer region of the IL-2 receptor alpha chain (p55).</clue>
</event>
<event id="E4">
<type class="Physiological_process"/>
<theme idref="T8"/>
<cause idref="E3"/>
<clue>We <clueKT>report</clueKT> here that interleukin 2 (IL-2) <clueType>acts</clueType> <linkTheme>on</linkTheme> human blood monocytes <linkCause>by</linkCause> enhancing binding activity of the transcription factor NF-kappa B to its consensus sequence in the 5&apos; regulatory enhancer region of the IL-2 receptor alpha chain (p55).</clue>
</event>
<sentence id="S3">Similarly, <term id="T17" lex="IL-2" sem="Protein_molecule">IL-2</term> activates <term id="T18" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> in the <term id="T19" lex="human_monocytic_cell_line_U_937" sem="Cell_cultured"><term id="T20" lex="human" sem="Multicellular_organism_natural">human</term> monocytic cell line U 937</term>, but not in <term id="T21" lex="resting_human_T-cell" sem="Cell_natural">resting <term id="T22" lex="human" sem="Multicellular_organism_natural">human</term> T-cells</term>.</sentence>
<event id="E5">
<type class="Positive_regulation"/>
<theme idref="T18"/>
<cause idref="T17"/>
<clue>Similarly, IL-2 <clueType>activates</clueType> NF-kappa B <clueLoc>in the human monocytic cell line U 937</clueLoc>, but not in resting human T-cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E6">
<type class="Positive_regulation"/>
<theme idref="T18"/>
<cause idref="T17"/>
<clue>Similarly, IL-2 <clueType>activates</clueType> NF-kappa B in the human monocytic cell line U 937, but <cluePolarity>not</cluePolarity> <clueLoc>in resting human T-cells</clueLoc>.</clue>
</event>
<sentence id="S4">This effect is detectable within 15 min and peaks 1 h after exposure to <term id="T23" lex="IL-2" sem="Protein_molecule">IL-2</term>.</sentence>
<sentence id="S5">Enhanced <term id="T24" lex="NF-kappa_B_binding_activity" sem="Other"><term id="T25" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> binding activity</term> is followed by functional activation in that inducibility of the <term id="T26" lex="IL-2_receptor_alpha_chain" sem="Protein_molecule"><term id="T27" lex="IL-2" sem="Protein_molecule">IL-2</term> receptor alpha chain</term> is mediated by enhanced <term id="T28" lex="NF-kappa_B_binding" sem="Other"><term id="T29" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> binding</term> and that a heterologous promoter containing the <term id="T30" lex="NF-kappa_B_consensus_sequence" sem="DNA_domain_or_region"><term id="T31" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> consensus sequence</term> (<term id="T32" lex="-291_to_-245" sem="DNA_domain_or_region">-291 to -245</term>) of the <term id="T33" lex="IL-2_receptor_alpha_chain_gene" sem="DNA_domain_or_region">IL-2 receptor alpha chain gene</term> is activated.</sentence>
<event id="E101">
<type class="Binding"/>
<theme idref="T25"/>
<clue>Enhanced NF-kappa B <clueType>binding activity</clueType> is followed by functional activation in that inducibility of the IL-2 receptor alpha chain is mediated by enhanced NF-kappa B binding and that a heterologous promoter containing the NF-kappa B consensus sequence (-291 to -245) of the IL-2 receptor alpha chain gene is activated.</clue>
</event>
<event id="E102">
<type class="Positive_regulation"/>
<theme idref="E101"/>
<clue><clueType>Enhanced</clueType> NF-kappa B binding activity is followed by functional activation in that inducibility of the IL-2 receptor alpha chain is mediated by enhanced NF-kappa B binding and that a heterologous promoter containing the NF-kappa B consensus sequence (-291 to -245) of the IL-2 receptor alpha chain gene is activated.</clue>
</event>
<event id="E103">
<type class="Positive_regulation"/>
<theme idref="T25"/>
<clue>Enhanced NF-kappa B binding activity is followed by <clueType>functional activation</clueType> in that inducibility of the IL-2 receptor alpha chain is mediated by enhanced NF-kappa B binding and that a heterologous promoter containing the NF-kappa B consensus sequence (-291 to -245) of the IL-2 receptor alpha chain gene is activated.</clue>
<comment>NO COREFTHEME</comment></event>
<event id="E104">
<type class="Positive_regulation"/>
<theme idref="E103"/>
<cause idref="E102"/>
<clue>Enhanced NF-kappa B binding activity is <clueType>followed</clueType> <linkTheme>by</linkTheme> functional activation in that inducibility of the IL-2 receptor alpha chain is mediated by enhanced NF-kappa B binding and that a heterologous promoter containing the NF-kappa B consensus sequence (-291 to -245) of the IL-2 receptor alpha chain gene is activated.</clue>
</event>
<event id="E9">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="E16"/>
<clue>Enhanced NF-kappa B binding activity is followed by functional activation in that inducibility of the IL-2 receptor alpha chain is <clueType>mediated</clueType> <linkCause>by</linkCause> enhanced NF-kappa B binding and that a heterologous promoter containing the NF-kappa B consensus sequence (-291 to -245) of the IL-2 receptor alpha chain gene is activated.</clue>
</event>
<event id="E10">
<type class="Positive_regulation"/>
<theme idref="T26"/>
<clue>Enhanced NF-kappa B binding activity is followed by functional activation in that <clueType>inducibility</clueType> <linkTheme>of</linkTheme> the IL-2 receptor alpha chain is mediated by enhanced NF-kappa B binding and that a heterologous promoter containing the NF-kappa B consensus sequence (-291 to -245) of the IL-2 receptor alpha chain gene is activated.</clue>
</event>
<event id="E11">
<type class="Binding"/>
<theme idref="T29"/>
<clue>Enhanced NF-kappa B binding activity is followed by functional activation in that inducibility of the IL-2 receptor alpha chain is mediated by enhanced NF-kappa B <clueType>binding</clueType> and that a heterologous promoter containing the NF-kappa B consensus sequence (-291 to -245) of the IL-2 receptor alpha chain gene is activated.</clue>
</event>
<event id="E16">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<clue>Enhanced NF-kappa B binding activity is followed by functional activation in that inducibility of the IL-2 receptor alpha chain is mediated by <clueType>enhanced</clueType> NF-kappa B binding and that a heterologous promoter containing the NF-kappa B consensus sequence (-291 to -245) of the IL-2 receptor alpha chain gene is activated.</clue>
</event>
<event id="E12">
<type class="Positive_regulation"/>
<theme idref="T33"/>
<cause idref="E16"/>
<clue>Enhanced NF-kappa B binding activity is followed by functional activation in that inducibility of the IL-2 receptor alpha chain is mediated <linkCause>by</linkCause> enhanced NF-kappa B binding and that a heterologous promoter containing the NF-kappa B consensus sequence (-291 to -245) of the IL-2 receptor alpha chain gene is <clueType>activated</clueType>.</clue>
</event>
<sentence id="S6">In addition, <term id="T34" lex="IL-2" sem="Protein_molecule">IL-2</term> is capable of increasing transcript levels of the <term id="T35" lex="p50" sem="DNA_domain_or_region">p50 gene</term> coding for the <term id="T36" lex="p50_subunit" sem="Protein_molecule">p50 subunit</term> of the <term id="T37" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> transcription factor, whereas <term id="T38" lex="mRNA_level" sem="Other"><term id="A1" sem="RNA_molecule">mRNA</term> levels</term> <term id="A2" sem="RNA_molecule">of the <term id="T39" lex="p65" sem="Protein_molecule">p65</term> <term id="T40" lex="NF-kappa_B_gene" sem="DNA_domain_or_region"><term id="T41" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> gene</term></term> remained unchanged.</sentence>
<event id="E13">
<type class="Transcription"/>
<theme idref="T35"/>
<clue>In addition, IL-2 is capable of increasing <clueType>transcript levels</clueType> <linkTheme>of</linkTheme> the p50 gene coding for the p50 subunit of the NF-kappa B transcription factor, whereas mRNA levels of the p65 NF-kappa B gene remained unchanged.</clue>
<comment>NER T35 MOD</comment></event>
<event CL="L2" KT="Analysis" id="E14">
<type class="Positive_regulation"/>
<theme idref="E13"/>
<cause idref="T34"/>
<clue>In addition, IL-2 is <clueKT><clueCL>capable of</clueCL></clueKT> <clueType>increasing</clueType> transcript levels of the p50 gene coding for the p50 subunit of the NF-kappa B transcription factor, whereas mRNA levels of the p65 NF-kappa B gene remained unchanged.</clue>
</event>
<event KT="Other" id="E17">
<type class="Transcription"/>
<theme idref="A1" idref1="A2"/>
<clue>In addition, IL-2 is capable of increasing transcript levels of the p50 gene coding for the p50 subunit of the NF-kappa B transcription factor, whereas mRNA <clueType>levels</clueType> of the p65 NF-kappa B gene remained unchanged.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E15">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="T34"/>
<clue>In addition, IL-2 is capable of increasing transcript levels of the p50 gene coding for the p50 subunit of the NF-kappa B transcription factor, whereas mRNA levels of the p65 NF-kappa B gene remained <clueType><cluePolarity>unchanged</cluePolarity></clueType>.</clue>
<comment>NO COREFCAUSE</comment></event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
